LBF News

Check out all the new things LBF is doing and hear about stories of our community here. Be sure to sign up for our news letter so you never miss an update!

Stay informed on the latest by subscribing to our newsletter!

For any PR & Media inquiries, please reach out to info@lilabeanfoundation.com

Jun 27, 20241 min read

AWS is providing $10 million to accelerate research for pediatric health care and to better understand rare diseases.

LBF Executive Director Nicole Giroux was honored to be in attendance at the Amazon Web Services DC Summit, when AWS announced a $10...

104 views0 comments

Day One Biopharmaceuticals Announces FDA approved of New Drug Application for relapsed or refractory pediatric low-grade glioma (pLGG)

LBF

Apr 24, 20241 min read

Day One Biopharmaceuticals Announces FDA approved of New Drug Application for relapsed or refractory pediatric low-grade glioma (pLGG)

Yesterday Day One Biopharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved their New Drug Application (NDA)...

18 views0 comments

Day One Announces Updated FIREFLY-1 Data for Tovorafenib

LBF

Sep 11, 20231 min read

Day One Announces Updated FIREFLY-1 Data for Tovorafenib

Today, Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling New Drug Application (NDA) submission to U.S....

40 views0 comments

Children’s National Hospital Receives $96 Million for Rare Brain Tumor Research & Care

LBF

Jul 7, 20231 min read

Children’s National Hospital Receives $96 Million for Rare Brain Tumor Research & Care

Children’s National received a $96 million investment from an anonymous donor family to transform rare childhood brain tumor research and...

21 views0 comments

FIRST-OF-ITS-KIND OPEN-ANALYSIS PLATFORM FOR PEDIATRIC BRAIN TUMORS PROVIDES ROBUST DATA RESOURCE

LBF

Jul 7, 20231 min read

FIRST-OF-ITS-KIND OPEN-ANALYSIS PLATFORM FOR PEDIATRIC BRAIN TUMORS PROVIDES ROBUST DATA RESOURCE

Collaboration among CHOP, Alex’s Lemonade Stand Foundation, the Pacific Pediatric Neuro-Oncology Consortium, and Children’s Brain Tumor...

9 views0 comments

Better Treatment Option for some Low-Grade Glioma Patients Becomes a Reality

Sarah Lilly

Mar 24, 20232 min read

Better Treatment Option for some Low-Grade Glioma Patients Becomes a Reality

March 16 marked a historic day for the pediatric brain cancer community with the passing of the first-ever drugs approved by the FDA to...

98 views0 comments

Looking to help fund a cure? Donate today!

Donate

LBF News

Check out all the new things LBF is doing and hear about stories of our community here. Be sure to sign up for our news letter so you never miss an update!

Stay informed on the latest by subscribing to our newsletter!

For any PR & Media inquiries, please reach out to info@lilabeanfoundation.com

AWS is providing $10 million to accelerate research for pediatric health care and to better understand rare diseases.

Day One Biopharmaceuticals Announces FDA approved of New Drug Application for relapsed or refractory pediatric low-grade glioma (pLGG)

Day One Announces Updated FIREFLY-1 Data for Tovorafenib

Children’s National Hospital Receives $96 Million for Rare Brain Tumor Research & Care

FIRST-OF-ITS-KIND OPEN-ANALYSIS PLATFORM FOR PEDIATRIC BRAIN TUMORS PROVIDES ROBUST DATA RESOURCE

Better Treatment Option for some Low-Grade Glioma Patients Becomes a Reality

Get Monthly Updates

Contact Us

Become an 11 for 11 Member

105 Rockdale Drive
Silver Spring, MD 20901

Back to Top

LBF News

Check out all the new things LBF is doing and hear about stories of our community here. Be sure to sign up for our news letter so you never miss an update! Stay informed on the latest by subscribing to our newsletter! For any PR & Media inquiries, please reach out to info@lilabeanfoundation.com

AWS is providing $10 million to accelerate research for pediatric health care and to better understand rare diseases.

Day One Biopharmaceuticals Announces FDA approved of New Drug Application for relapsed or refractory pediatric low-grade glioma (pLGG)

Day One Announces Updated FIREFLY-1 Data for Tovorafenib

Children’s National Hospital Receives $96 Million for Rare Brain Tumor Research & Care

FIRST-OF-ITS-KIND OPEN-ANALYSIS PLATFORM FOR PEDIATRIC BRAIN TUMORS PROVIDES ROBUST DATA RESOURCE

Better Treatment Option for some Low-Grade Glioma Patients Becomes a Reality

Get Monthly Updates

Contact Us

Become an 11 for 11 Member

105 Rockdale Drive Silver Spring, MD 20901

Back to Top

Check out all the new things LBF is doing and hear about stories of our community here. Be sure to sign up for our news letter so you never miss an update!

Stay informed on the latest by subscribing to our newsletter!

For any PR & Media inquiries, please reach out to info@lilabeanfoundation.com

105 Rockdale Drive
Silver Spring, MD 20901